Clarity Pharmaceuticals (ASX:CU6) Releases Q4 Activity Report
Clarity Pharmaceuticals (ASX:CU6) reports strong Q4 financials, significant trial progress, and entry into the ASX200 index.
Clarity Pharmaceuticals (ASX:CU6) reports strong Q4 financials, significant trial progress, and entry into the ASX200 index.
Inventis Limited (ASX:IVT) reports significant Q2 orders, initiates a $2.5M USD capital raise, and announces strategic partnerships to drive international growth.
Arcadia Minerals (ASX:AM7) reports on project developments and financial performance in its latest quarterly activities report.
True North Copper Limited (ASX:TNC) resumes ASX trading after successful recapitalisation, securing a debt-free balance and expanding exploration projects.
AustChina Holdings (ASX:AUH) releases its Q4 2024 report, detailing project developments and strategic investments in mineral resources.
Freehill Mining Limited (ASX:FHS) reports a 100% increase in Q4 gross sales and improved cash flow, driven by robust demand and strategic operations.
Rapid Lithium Limited (ASX:RLL) completes Midwest acquisition, launches $2M capital raise, and updates on strategic projects.
Papyrus Australia Ltd (ASX:PPY) reports Q4 activities including a Vietnam joint venture, new board members, and significant financial achievements.
ReNu Energy (ASX:RNE) reports Q4 2024 activities, including a management buyout proposal, asset sales, and financial updates.
Marquee Resources (ASX:MQR) reports significant exploration progress and strong financial updates in its Q4 2024 Activities Report.